PURE Bioscience
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.26-2.67-12.17-5.04-3.61-19.59K-15.78-5.00-2.39-2.66-3.30-3.61
Price/Sales ratio
34.0844.9743.3421.2712.4016.999.329.445.044.547.4016.99
Price/Book Value ratio
10.4211.5461.5229.4619.9024.4310.984.4734.81-3.116.4624.43
Price/Cash Flow ratio
-4.09-11.61-17.39-9.71-7.92175.72-31.37-7.23-2.88-3.52-2.57-7.92
Price/Free Cash Flow ratio
-4.02-10.74-16.57-9.62-7.88192.40-21.69-7.00-2.85-3.52-2.50-7.88
Price/Earnings Growth ratio
0.05-0.020.16-0.500.19196.15-0.00-0.100.240.160.09196.15
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
60.90%65.78%58.49%56.98%61.86%58.13%52.83%53.96%51.73%58.68%49.39%58.13%
Operating Profit Margin
-1048.01%19.16%-328.12%-396.95%-292.77%0.13%-58.84%-184.83%-210.06%-159.50%-223.55%-292.77%
Pretax Profit Margin
-1046.22%-1114.89%-342.05%-419.50%-343.32%0.05%-59.05%-188.39%-211.02%-170.65%-224.27%-343.32%
Net Profit Margin
-1044.44%-1682.31%-355.98%-421.36%-343.68%-0.08%-59.05%-188.72%-211.02%-170.65%-224.27%-343.68%
Effective Tax Rate
0.17%-50.89%-4.07%-0.44%-0.10%250%2.95%-0.17%-0.25%N/AN/A-0.10%
Return on Assets
-233.48%-286.76%-170.22%-290.29%-339.59%-0.09%-53.89%-77.98%-217.04%-409.53%-159.92%-339.59%
Return On Equity
-319.51%-431.71%-505.27%-583.52%-551.34%-0.12%-69.57%-89.46%-1456.25%116.96%-153.49%-551.34%
Return on Capital Employed
-319.39%4.91%-461.79%-544.20%-468.09%0.18%-69.33%-87.61%-304.94%-3683.52%-195.11%-468.09%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A4.19N/A
Quick Ratio
2.032.280.860.981.173.312.956.402.841.023.541.17
Cash ratio
1.522.040.640.660.532.532.465.892.050.573.200.53
Days of Sales Outstanding
94.6274.4759.2056.5871.3157.4634.2039.5955.4255.4131.5657.46
Days of Inventory outstanding
265.10289.68131.1194.2388.7468.9465.4376.5935.4525.2079.9579.95
Operating Cycle
359.73364.15190.31150.82160.06126.4099.63116.1890.8780.6187.73126.40
Days of Payables Outstanding
717.19396.45204.59290.85277.25169.39116.87208.81170.01270.48138.72169.39
Cash Conversion Cycle
-357.45-32.29-14.27-140.03-117.19-42.98-17.23-92.62-79.13-189.87-87.44-117.19
Debt Ratios
Debt Ratio
N/AN/AN/A0.19N/AN/A0.05N/A0.553.600.18N/A
Debt Equity Ratio
N/AN/AN/A0.39N/AN/A0.07N/A3.75-1.020.22N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/A0.7834.69N/AN/A
Total Debt to Capitalization
N/AN/AN/A0.28N/AN/A0.06N/A0.7834.69N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-504.12N/A
Cash Flow to Debt Ratio
N/AN/AN/A-7.72N/AN/A-4.88N/A-3.21-0.85N/AN/A
Company Equity Multiplier
1.361.502.962.011.621.311.291.146.70-0.281.221.31
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-8.31-3.87-2.49-2.19-1.560.09-0.29-1.30-1.74-1.28-2.870.09
Free Cash Flow / Operating Cash Flow Ratio
1.011.081.041.001.000.911.441.031.0111.021.00
Cash Flow Coverage Ratio
N/AN/AN/A-7.72N/AN/A-4.88N/A-3.21-0.85N/AN/A
Short Term Coverage Ratio
N/AN/AN/A-7.72N/AN/A-4.88N/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A